At NYSCC Suppliers’ Day, Sabinsa is unveiling Mangiophelin, a mango-derived active designed to simplify anti-aging formulation without compromising performance. Derived from immature deseeded dry fruit of Mangifera indica, the ingredient is standardized to contain a minimum of 10% polyphenols and 1% mangiferin, positioning it as a potent antioxidant solution for both topical and ingestible beauty applications.
Positioned as a comprehensive anti-aging active to address nine visible signs of aging in a single ingredient, Mangiophelin targets wrinkles, roughness, dullness, age spots, sagging, elasticity loss, uneven tone and blemishes. The multifunctional approach aligns with growing consumer demand for streamlined, high-efficacy formulations that deliver broad-spectrum skin benefits.
What sets Mangiophelin apart is its dual-format versatility. Effective in both topical skin care and oral beauty-from-within applications, the ingredient taps directly into the accelerating nutricosmetics movement, where consumers increasingly view skin health through a holistic wellness lens. By combining antioxidant-rich polyphenols with mangiferin, a bioactive known for its protective and rejuvenating properties, the ingredient is engineered to support visible skin vitality from multiple pathways.
For formulators looking to bridge performance skin care and ingestible beauty, Mangiophelin offers a single active with broad claims potential, clean botanical positioning and cross-category flexibility—all anchored in the growing appeal of mango-based bioactives.
